Piper Sandler Reiterates Overweight Rating on Day One Biopharmaceuticals (DAWN)
Go back to Piper Sandler Reiterates Overweight Rating on Day One Biopharmaceuticals (DAWN)| Dawn Technologies, Inc. (NASDAQ: DAWN) | Delayed: 21.53 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $21.53 | 52 Week High | $0.01 | |||
| Open | $21.53 | 52 Week Low | $0.00 | |||
| Day High | $21.53 | P/E | N/A | |||
| Day Low | $21.53 | EPS | $0.00 | |||
| Volume | 3,273,647 | |||||
